We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $156B
1-Year Est. Return 27.51%
This Fund
S&P 500
This Quarter Est. Return
+4%
1 Year Est. Return
+27.51%
3 Year Est. Return
+75.53%
5 Year Est. Return
+102.92%
10 Year Est. Return
+480.77%
AUM
$25B
AUM Growth
+$788M
Cap. Flow
-$383M
Cap. Flow %
-1.53%
Top 10 Hldgs %
6.32%
Holding
1,699
New
42
Increased
1,041
Reduced
462
Closed
65

Top Sells

Rank Stock Value
1
PRGO icon
Perrigo
PRGO
+$106M
2
CERN
Cerner Corp
CERN
+$85.7M
3
BBWI icon
Bath & Body Works
BBWI
+$80.6M
4
HRL icon
Hormel Foods
HRL
+$80M
5
TOL icon
Toll Brothers
TOL
+$78.4M

Sector Composition

Rank Sector Weight
1 Financials 15.96%
2 Industrials 14.62%
3 Technology 12.79%
4 Consumer Discretionary 8.75%
5 Healthcare 8.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NBIX icon
1551
Neurocrine Biosciences
NBIX
$16.8B
$26K ﹤0.01%
572
+74
+15% +$3.41K
WNS
1552
DELISTED
WNS Holdings
WNS
$26K ﹤0.01%
955
-670
-41% -$20.4K
XLV icon
1553
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
$26K ﹤0.01%
369
AMPH icon
1554
Amphastar Pharmaceuticals
AMPH
$879M
$25K ﹤0.01%
1,557
+202
+15% +$2.85K
HTHT icon
1555
Huazhu Hotels Group
HTHT
$13.1B
$24K ﹤0.01%
2,688
-2,756
-51% -$24.3K
XLK icon
1556
State Street Technology Select Sector SPDR ETF
XLK
$115B
$24K ﹤0.01%
+1,100
New +$23.9K
IMMR icon
1557
Immersion
IMMR
$251M
$23K ﹤0.01%
3,186
+127
+4% +$894
CPHD
1558
DELISTED
Cepheid Inc
CPHD
$23K ﹤0.01%
753
+336
+81% +$10.2K
FOSL icon
1559
Fossil Group
FOSL
$293M
$22K ﹤0.01%
767
+335
+78% +$11.3K
PTLA
1560
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$22K ﹤0.01%
924
+137
+17% +$3.38K
DXCM icon
1561
DexCom
DXCM
$31.5B
$21K ﹤0.01%
1,036
DVAX
1562
DELISTED
Dynavax Technologies
DVAX
$20K ﹤0.01%
1,348
+157
+13% +$2.68K
ACFC
1563
DELISTED
Atlantic Coast Financial Corporation
ACFC
$20K ﹤0.01%
3,362
DO
1564
DELISTED
Diamond Offshore Drilling
DO
$20K ﹤0.01%
823
-23
-3% -$548
UE icon
1565
Urban Edge Properties
UE
$2.86B
$19K ﹤0.01%
637
PCRX icon
1566
Pacira BioSciences
PCRX
$1.04B
$18K ﹤0.01%
525
+22
+4% +$1.08K
FLXN
1567
DELISTED
Flexion Therapeutics, Inc.
FLXN
$18K ﹤0.01%
1,214
+25
+2% +$314
GNMX
1568
DELISTED
Aevi Genomic Medicine Inc
GNMX
$18K ﹤0.01%
3,304
+130
+4% +$683
NVEE
1569
DELISTED
NV5 Global
NVEE
$16K ﹤0.01%
2,304
NWS icon
1570
News Corp Class B
NWS
$16.9B
$16K ﹤0.01%
1,376
-38
-3% -$474
WPM icon
1571
Wheaton Precious Metals
WPM
$49.5B
$16K ﹤0.01%
698
XLE icon
1572
State Street Energy Select Sector SPDR ETF
XLE
$39.6B
$16K ﹤0.01%
456
KERX
1573
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$16K ﹤0.01%
2,443
+51
+2% +$285
ACAD icon
1574
Acadia Pharmaceuticals
ACAD
$4.43B
$14K ﹤0.01%
443
+9
+2% +$301
LCNB icon
1575
LCNB Corp
LCNB
$282M
$14K ﹤0.01%
865

Similar funds

Victory Capital Management's Q2 2016 Portfolio in Review

As of Q2 2016, Victory Capital Management held 1,699 positions worth $25B, up 3.3% from $24.2B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.

Victory Capital Management's Q2 2016 filing shows 42 new, 1,041 increased, 462 reduced and 65 closed positions. Its largest new stake was PDC Energy, Inc.: 1,959,506 shares worth $113M. The largest sale was Perrigo, an estimated $106M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 16% a quarter earlier, followed by Industrials and Technology.

  • Victory Capital Management's largest Q2 2016 buy was PDC Energy, Inc.: 1,959,506 shares worth $113M.
  • Victory Capital Management added most to Agilent Technologies in Q2 2016, an estimated $98.5M increase.
  • Victory Capital Management's biggest Q2 2016 reduction was Perrigo, cutting an estimated $106M.
  • Victory Capital Management fully exited Liberty Media Series C in Q2 2016, selling an estimated $68.4M.
  • Victory Capital Management's ten largest holdings make up 6.3% of its $25B portfolio in Q2 2016.
  • Victory Capital Management opened 42 new positions and closed 65 in Q2 2016.
  • Victory Capital Management's portfolio value rose 3.3% quarter-over-quarter to $25B.

Based on Victory Capital Management's 13F filing for Q2 2016, filed 9 Aug 2016.